ArticleBMC infectious diseases2026
Association between maintenance dialysis and tuberculosis treatment outcomes in Amazonas, Brazil: a population-based record-linkage cohort study (2001-2023) : Maintenance Dialysis and Tuberculosis Outcomes.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough maintenance dialysis (MD) affects only a small proportion of patients with tuberculosis (TB), individuals receiving dialysis are at increased risk of TB and may be more likely to experience unfavourable treatment outcomes. Evidence on this association remains limited in Brazil, particularly in high-burden settings characterized by geographic barriers and challenges in access to specialized healthcare services. We assessed the association between MD and unfavourable TB treatment outcomes in Amazonas, Brazil.
methodsWe conducted a retrospective population-based cohort study including all new TB cases reported in Amazonas, Brazil, between 2001 and 2023. Probabilistic record linkage was performed between the state TB surveillance system (SINAN-TB) and a dialysis registry to identify patients receiving MD before TB diagnosis. The primary exposure was MD prior to TB diagnosis. Unfavourable outcomes comprised death from any cause, loss to follow-up, or treatment failure. Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs).
resultsAmong 58,611 TB cases included in the analysis, 112 (0.2%) had evidence of MD before TB diagnosis. MD was strongly associated with higher odds of unfavourable outcomes (aOR 5.45; 95% CI 3.60-8.24). Illicit drug use (aOR 2.18; 95% CI 1.97-2.40), HIV/AIDS (aOR 2.06; 95% CI 1.94-2.19), mental illness (aOR 1.53; 95% CI 1.27-1.83), alcohol use (aOR 1.38; 95% CI 1.29-1.48), and smoking (aOR 1.30; 95% CI 1.20-1.42) were also associated with increased odds of unfavourable outcomes. In contrast, directly observed therapy (DOT) (aOR 0.67; 95% CI 0.63-0.71), female sex (aOR 0.82; 95% CI 0.79-0.85), and diabetes mellitus (aOR 0.84; 95% CI 0.78-0.91) were associated with reduced odds.
conclusionsWithin a large population-based TB cohort, MD was a rare but clinically important exposure that was strongly associated with unfavourable treatment outcomes. The protective effect of DOT highlights a feasible intervention pathway. These findings support the integration of TB care into dialysis services and reinforce the need to prioritize this population for targeted TB screening and preventive strategies in high-burden settings. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.